CRH — CRH plc

The market is clearly bearish on the tape even though the fundamentals aren't: as of 2026-09-13 the shares had fallen -6.06% over one week, -9.63% over one month and -16.84% over three months, pushing the price to $88.55 versus a 52-week range of $86.84-$131.55. Drivers look macro/sentiment-led rather than operational - elevated rates weighing on private residential and commercial construction, the temporary pause in share buybacks tied to the Arcosa acquisition announced June 22, 2026, and likely profit-taking after a strong prior run. Notably, sell-side consensus remains a Buy with a $135.60 average target (~53% upside), so analysts and the tape are pointed in opposite directions.

The FMP quarterly series is comparability-compromised (the deterministic score's own notes flag a -46% revenue move into 2023-06-30 and a +55% move into 2024-09-30, consistent with the NYSE/reporting transition and the Building Envelope divestiture), so I lean on the clean organic figures. On that basis the trend is stable-to-improving, not deteriorating: Q2 2026 revenue was $10.78B (+6% YoY), net income $1.486B (+13%), adjusted EBITDA $2.6B (+7%) with margin up 30bps to 24.4%, and diluted EPS $2.21 (+14%) beating the $2.03 consensus. Reported operating margin held ~19.3% (Q2 2026) versus ~18.8% (Q3 2025) and gross margin ~39.9% versus ~38.9% - i.e. modest pricing-driven margin expansion. The key divergence is that operating earnings are marching up while the share price marches down, which is a sentiment/multiple story, not an earnings story. One blemish: Q2 2026 free cash flow slipped to $490M from $602M a year earlier as capex rose to $639M, so cash conversion deserves watching.

Mixed, but cheap where it matters. As of 2026-09-13 the trailing P/E of 19.9x sits above the 5-year average of 16.2x and P/S of 2.71x is well above the 5-year 1.65x - the basis for the deterministic score's 'Rich vs. its own history' tag. But those are trailing artifacts: on FY2026 guidance EPS of $5.60-$6.05 (midpoint $5.83) the forward P/E is ~15.2x, and on next-FY consensus EPS of $5.88 it is ~15.1x - below the company's own 5-year average and a discount to US aggregates pure-plays. PEG of 0.678 also screens cheap, though that figure is noisy. The setup is a business whose earnings are inflecting up while the multiple compresses - the opposite of 'rich' on a go-forward basis.

This is a textbook 'price down, earnings up' divergence. Management reaffirmed FY2026 guidance ($3.9-4.1B net income, $5.60-$6.05 EPS, $8.1-8.5B adjusted EBITDA), the Q2 print beat, and the sell-side target sits near $135 - yet the stock has fallen to the low end of its 52-week range. That means the market is either (a) early, pricing a macro-driven construction slowdown or rate-hike risk that hasn't shown up in the numbers yet, or (b) correctly anticipating pressure the estimates don't yet reflect. Given >75% of EBITDA comes from North America with multi-year IIJA-funded public works underwriting the top line, I read the gap as the market underpricing the earnings trajectory - but the momentum collapse means there's no confirmation yet and caution is warranted on timing.

Unambiguously weak. As of 2026-09-13 RSI(14) stood at 35.68 - approaching but not yet at oversold - with price 5.32% below the 20-day SMA, 9.84% below the 50-day SMA and 20.28% below the 200-day SMA, and every return window (1wk -6.06%, 1mo -9.63%, 3mo -16.84%, 6mo -11.29%) negative. This is a sustained downtrend sitting on the 52-week low, not a range. RSI near 35 could produce a dead-cat bounce, but there is no base, no reclaim of the 50-day, and no momentum signal yet; the entry-timing implication is to wait for stabilization (a higher low or a 50-DMA reclaim) rather than catching a falling knife.

• US infrastructure spending: IIJA-funded public works provide a multi-year, federally backed revenue floor, and >75% of CRH EBITDA is North American - a genuine cyclical insulator versus pure residential names.
• Interest rates: elevated rates remain a drag on private residential and commercial construction, the softer part of CRH's end-market mix, though public works are largely rate-insulated.
• Data centers, reshoring and manufacturing construction: management notes >85% of US data centers sit within 25 miles of a CRH plant, giving direct leverage to high-intensity utility and tech construction.
• Input and labor cost inflation: being offset by disciplined pricing (mid-single-digit aggregate increases), which is what is holding margins flat-to-up rather than compressing them.
• Currency and cross-listing effects: CRH reports in USD but retains European/other operations, so FX translation adds noise, and the 2023 move to a primary US listing still distorts some reported comparability.

• Q3 2026 results (typically late October/early November 2026): the next real read on aggregates volume growth and price realization versus the reaffirmed FY guidance.
• Arcosa transaction: regulatory clearance and closing would expand the US aggregates footprint and energy-infrastructure exposure - strategic positive but leverage-adding.
• Buyback resumption: tranches were paused during the Arcosa process; restarting them removes an overhang on the share count and signals confidence.
• Dividend of $0.39/share paid September 16, 2026 (record August 14), a 5% YoY increase - small but a steady capital-return signal.
• Rate cuts: any easing that revives residential/commercial construction volumes would be the clearest re-rating catalyst for the currently depressed multiple.

• Prolonged high rates or a housing-led construction slowdown: would eventually bite volumes even with public-works support, and the market is already pricing some of this.
• Arcosa integration and leverage: long-term debt rose to $15.41B at 2026-06-30 from $12.58B a year earlier, and the deal adds execution and balance-sheet risk while buybacks are paused.
• Cyclicality: construction materials demand is inherently tied to the economic cycle, and ROIC of 8.2% is only roughly cost-of-capital - not a lot of cushion if volumes roll over.
• Cash conversion/FCF volatility: Q2 2026 FCF fell to $490M from $602M YoY, and the business has seasonal swings (Q1 2024 FCF was -$1.13B) that can spook investors.
• Data comparability: the reporting/divestiture distortions flagged in the deterministic score's notes make historical trend analysis genuinely unreliable and could mask either improvement or deterioration.

CRH is a genuinely good, infrastructure-levered building-materials business trading in a broken tape. The operating story is intact - mid-single-digit organic growth, 30bps of EBITDA margin expansion, a 14% EPS beat, reaffirmed FY2026 guidance, and years of IIJA and data-center construction demand ahead. On forward earnings, ~15x versus its own ~16.2x 5-year average looks cheap, and the sell-side sees ~53% upside. But the stock is 20% below its 200-day moving average, at the low end of its range, with no technical stabilization, and it carries real cyclical, leverage and cash-conversion risk. This is a reasonable accumulation zone for a patient, long-horizon investor and a poor entry for anyone who needs the price to work now; the honest read is neutral - a solid business, a cheap-looking forward multiple, and a market that has not yet agreed.

I applied a 17x multiple - justified by CRH's ~16.2x 5-year average P/E plus a modest premium for its dominant US-infrastructure mix and mid-teens EPS growth - to next-FY consensus EPS of $5.88, giving ~$100 (equivalent to ~15.2x the FY2026 guidance midpoint of $5.83). Cross-checking with EV/EBITDA: ~$59.2B market cap plus ~$13B net debt on ~$8.3B FY2026 adjusted EBITDA midpoint implies ~8.7x, and marking that to a ~9.5x fair multiple (a discount to US aggregates peers) lands within a dollar or two of $100, so I use $100 as the intrinsic value as of 2026-09-13 - well below the $135.60 sell-side consensus, which I view as too generous a multiple for a capital-intensive cyclical.